Let the value share Record the pace of enterprise development
2023
Multiple myeloma (MM) is a heterogeneous malignant plasma cell tumor and is one of the most common hematological malignancies. The number of new cases of MM in China in 2022 is 22,400. The first-line treatment of MM includes chemical drug combination...
2023
Protein-protein interaction (PPI) is the process of combining two or more proteins and participates in the regulation of many aspects of life processes. How to establish an efficient and accurate PPI prediction model has always been a hot and difficu...
2023
On August 1, 2023 in Chengdu, China, Chengdu Shengshi Junlian Biotechnology Co., Ltd. (hereinafter referred to as "Shengshi Junlian") announced that it has entered into an An antibody transfer agreement achieves first milestone.In February 2023, Shen...
2023
"Garbage in, Garbage out", high-quality data has always been considered the basis for AI model training. So what is "high-quality data"? How are these data obtained? Today we would like to introduce an article published in Nature Biomedical Engineeri...
2023
Recently, the 2-day China AI Drug Research and Development Conference (CAPR 2023) was held in Shanghai. The conference set up a main forum and 6 sub-forums. From the aspects of how AI affects small molecule drug design, macromolecule drug design, prot...
2023
The article "Novel application of anti-human Fc nanobody for screening high-producing CHO cells for monoclonal antibody" published by Shengshi Junlian in the journal "ENGINEERING IN LIFE SCIENCES" immediately attracted widespread attention from the i...
2023
Transcription factors (TFs) regulate gene programs, thereby controlling different cellular processes and cell states.On January 5th, 2023, the team led by Feng Zhang from the Broad Institute/Harvard Medical School/Massachusetts Institute of Technolog...
2023
Recently, the journal Science published an article stating that the FDA will no longer require animal testing before clinical trials of drugs.On September 29, 2022, the United States Senate unanimously passed the FDA Modernization Act 2.0, aimed at s...
2020
Recently, it was learned from Chengdu Shengshi Junlian Biotechnology Co., Ltd. (referred to as "ABLINK"), located in the Tianfu Life Science Park in Chengdu Hi-tech Zone, that they have successfully screened neutralizing antibodies against SARS-CoV-2...
